A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says
Results of a large clinical trial found the treatment did [...]
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment’s manufacturer, Amylyx, said they would announce [...]
A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicine
An A.L.S. drug rejected by the F.D.A. made me rethink [...]
FDA Approves Biogen’s Drug for Rare Form of ALS
The drug, which will be sold as Qalsody by the [...]
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
The list price of the therapy, Relyvrio, is much higher [...]
FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may [...]
New Experimental Therapy for A.L.S. Approved in Canada
The F.D.A. is also reviewing the treatment, Albrioza, but the [...]
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
With a 6-4 vote, the group of independent advisers to [...]